Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 9/20 | 0.48 |
| ▸ | NPC1 | O15118 | 8/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5286514 | 0.79 | SMN1; SMN2 (0.57) | NOTUMRAB9ANPC1SMN1; SMN2MAPT | |
| SCHEMBL5283894 | 0.78 | VHL (0.49) | RAB9ANPC1SMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL16545889 | 0.78 | NOTUM (0.63) | NOTUMRAB9ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL4142743 | 0.77 | NOTUM (0.67) | NOTUMRAB9ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL5282505 | 0.77 | NOTUM (0.51) | NOTUMRAB9ANPC1SMN1; SMN2L3MBTL1 | |
| SCHEMBL5281369 | 0.75 | EPHX2 (0.40) | RAB9ANPC1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL5287986 | 0.73 | SMN1; SMN2 (0.37) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL31225490 | 0.72 | SMN1; SMN2 (0.55) | SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL6937307 | 0.71 | SMN1; SMN2 (0.67) | SMN1; SMN2L3MBTL1POLBMAPTALDH1A1 | |
| SCHEMBL10045022 | 0.70 | SMN1; SMN2 (0.52) | NOTUMRAB9ANPC1SMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | CLSPN, LMAN2, RPN2 | NOTUM 3506/4885RAB9A 20/4885NPC1 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.